-Andrew D Mesecar Researcher Activity Profile

Research Author Detailed Information 

Andrew D Mesecar Publication Rate By Year

Andrew D Mesecar has published 1 paper(s) in 2005, 1 paper(s) in 2006, 11 paper(s) in 2007, for a total of 13 research publications in total.

Andrew D Ad Mesecar Author Information

LAST NAME: mesecar

FIRST NAME: Andrew D

INITIALS: ad

AFFILIATION:

Papers

Andrew D Mesecar's Publication Record

1. Screening method for the discovery of potential cancer chemoprevention agents based on mass spectrometric detection of alkylated Keap1. Year Published: 2005
Department of Medicinal Chemistry and Pharmacognosy, University of Illinois College of Pharmacy, 833 South Wood Street, Chicago, Illinois 60612-7231, USA.
2. Deubiquitinating activity of the SARS-CoV papain-like protease. Year Published: 2006
Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.
3. An ELISA method to measure inhibition of the COX enzymes. Year Published: 2007
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, College of Pharmacy, Nursing and Health Sciences, and The Purdue Cancer Center, Purdue University, West Lafayette, Indiana 47907, USA.
4. Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63. Year Published: 2007
Department of Microbiology and Immunology, Loyola University Medical Center, 2160 South First Avenue, Bldg. 105, Rm. 3929, Maywood, IL 60153, USA.
5. Structural and functional analysis of two glutamate racemase isozymes from Bacillus anthracis and implications for inhibitor design. Year Published: 2007
Center for Pharmaceutical Biotechnology, University of Illinois at Chicago, Chicago, IL 60607, USA.
6. Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors. Year Published: 2007
Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, IN 47907, USA. akghosh@purdue.edu
7. Sites of alkylation of human keap1 by natural chemoprevention agents. Year Published: 2007
Department of Medicinal Chemistry and Pharmacognosy, University of Illinois College of Pharmacy, Chicago, Illinois, USA.
8. Identification of the Highly Reactive Cysteine 151 in the Chemopreventive Agent-Sensor Keap1 Protein is Method-Dependent. Year Published: 2007
mesecar@uic.edu.
9. Sites of alkylation of human Keap1 by natural chemoprevention agents. Year Published: 2007
Department of Medicinal Chemistry and Pharmacognosy, University of Illinois College of Pharmacy, Chicago, Illinois, USA.
10. Sites of alkylation of human Keap1 by natural chemoprevention agents. Year Published: 2007
Department of Medicinal Chemistry and Pharmacognosy, University of Illinois College of Pharmacy, Chicago, Illinois, USA.
11. Identification of the highly reactive cysteine 151 in the chemopreventive agent-sensor Keap1 protein is method-dependent. Year Published: 2007
The Center for Pharmaceutical Biotechnology, and Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago 60607, USA.
12. Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors. Year Published: 2007
Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, IN 47907, USA. akghosh@purdue.edu
13. An ELISA method to measure inhibition of the COX enzymes. Year Published: 2007
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, College of Pharmacy, Nursing and Health Sciences, and The Purdue Cancer Center, Purdue University, West Lafayette, Indiana 47907, USA.